Sulukast

This classification denotes a bronchodilator with the molecular formula C25H36N4O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier M652A5186T, chemically known as 3-(((1r,2e,4z)-1-((alphas)-alpha-hydroxy-m-1h-tetrazol-5-ylbenzyl)-2,4-tetradecadienyl)thio)propionic acid but generally known as sulukast, which bears US NIH Compound Identifier 6436123. European Medicines Agency schedules Sulukast in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10766MIG. The term SULUKAST is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 5, No. 3 1991, List 31). SULUKAST is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule sulukast under HS 29339990 and SITC 51577. As of Q4 2014, SULUKAST remains the US FDA Preferred Term for this commodity. Sulukast bears US NLM identifiers UMLS ID C2699726 and NCI Concept Code C76576. SMILES: S(C(C(O)C1CC(CCC1)C1N[NH]NN1)/C=C/C=C/CCCCCCCCC)CCC(=O)O.